TSX News -
Notice of Knight Therapeutics’ Fourth Quarter 2019 Results Conference Call and update due to COVID-19 pandemic
MONTREAL, March 27, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, […]